EyePoint Pharmaceuticals Inc

NASDAQ:EYPT   11:48:05 AM EDT
0.51
+0.03 (+5.71%)
Other Pre-Announcement

Eyepoint Pharmaceuticals Says Q3 2020 Net Product Revenues Are Estimated To Be Between $5.5 Mln to $5.9 Mln

Published: 10/07/2020 11:50 GMT
pSivida Corp (EYPT) - Eyepoint Pharmaceuticals Announces Preliminary Net Product Revenue for Third Quarter 2020.
Eyepoint Pharmaceuticals Inc Says Q3 2020 Net Product Revenues Are Estimated to Be Between $5.5 - $5.9 Million.
Eyepoint Pharmaceuticals Inc - Sequential Increase in Underlying Customer Demand for Both Yutiq and Dexycu From Q2 2020.